Clinical Trial Update: Comparison Between OFDI and IVUS in PCI Guidance for Biolimus A9 Eluting Stent Implantation [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing OFDI and IVUS guidance for Biolimus A9 eluting stent implantation in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biolimus A9-eluting stent (biolimus A9-eluting stent)

Snippet

Sponsor: Fujita Health University | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN